TickerFacts.

BioNexus Gene Lab Corp (BGLC): Operating Income

Annual figures by period end, from SEC filings.

-$2.97M
Year ended 2025-12-31
-$2.56M
Trailing 12 months to 2026-06-30
$1.27M2018-12-31: $59.9K2019-12-31: -$275.7K2020-12-31: $1.27M2021-12-31: $1.06M2022-12-31: -$291.2K2023-12-31: -$2.59M2024-12-31: -$1.57M2025-12-31: -$2.97M-$2.97M
2018-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$2.97Mn/m2026-04-14, From 2025-01-01
2024-12-31-$1.57Mn/m2026-04-14, From 2024-01-01
2023-12-31-$2.59Mn/m2025-04-15, From 2023-01-01
2022-12-31-$291.2Kn/m2024-04-16, From 2022-01-01
2021-12-31$1.06M-17.1%2023-03-31, From 2021-01-01
2020-12-31$1.27Mn/m2022-04-06, From 2020-01-01
2019-12-31-$275.7Kn/m2021-03-30, From 2019-01-01
2018-12-31$59.9Kn/a2020-03-31, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
BioNexus Gene Lab Corp (BGLC)2025-12-31-$2.97Mn/m
American Shared Hospital Services (AMS)2025-12-31-$3.59Mn/m
Exagen Inc. (XGN)2025-12-31-$14.07Mn/m
Personalis, Inc. (PSNL)2025-12-31-$88.06Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m
YD Bio Ltd (YDES)2025-12-31-$5.27Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$562.16Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$16.02Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$91.10Mn/m

Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗